A multidisciplinary team of basic and clinical investigators directs all projects within the MSKCC-Cornell Center for Translation of Cancer Nanomedicines (MC2TCN). These teams participate fully in the broad research endeavor, striving to use insights from each project to develop and further the aims of the other projects. The “team science” approach extends beyond the boundaries of MC2TCN to include vital collaborations with other academic institutions, CCNEs, federal agencies, and industry.
The strengths that will enable our Center to initiate projects like the ones below include: outstanding researchers from diverse fields of expertise, experienced leadership, collaborations with members of the NCI Alliance for Nanotechnology, and supplemental financial support from key grants and institutional funds.